AU2007299043B2 - Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field - Google Patents
Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field Download PDFInfo
- Publication number
- AU2007299043B2 AU2007299043B2 AU2007299043A AU2007299043A AU2007299043B2 AU 2007299043 B2 AU2007299043 B2 AU 2007299043B2 AU 2007299043 A AU2007299043 A AU 2007299043A AU 2007299043 A AU2007299043 A AU 2007299043A AU 2007299043 B2 AU2007299043 B2 AU 2007299043B2
- Authority
- AU
- Australia
- Prior art keywords
- stem cells
- treatment
- pharmaceutical composition
- mammals
- adult stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 69
- 210000004504 adult stem cell Anatomy 0.000 title claims abstract description 29
- 210000004369 blood Anatomy 0.000 title claims abstract description 23
- 239000008280 blood Substances 0.000 title claims abstract description 23
- 210000005259 peripheral blood Anatomy 0.000 title claims abstract description 22
- 239000011886 peripheral blood Substances 0.000 title claims abstract description 22
- 238000011282 treatment Methods 0.000 claims abstract description 54
- 210000000130 stem cell Anatomy 0.000 claims abstract description 50
- 238000000338 in vitro Methods 0.000 claims abstract description 19
- 238000000746 purification Methods 0.000 claims abstract description 12
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims abstract 12
- 101710127797 Macrophage colony-stimulating factor 1 Proteins 0.000 claims abstract 12
- 210000004027 cell Anatomy 0.000 claims description 60
- 230000003902 lesion Effects 0.000 claims description 41
- 241000124008 Mammalia Species 0.000 claims description 26
- 230000007170 pathology Effects 0.000 claims description 26
- 239000008194 pharmaceutical composition Substances 0.000 claims description 25
- 239000003814 drug Substances 0.000 claims description 21
- 210000002435 tendon Anatomy 0.000 claims description 17
- 241000282472 Canis lupus familiaris Species 0.000 claims description 14
- 241000283086 Equidae Species 0.000 claims description 14
- 230000002860 competitive effect Effects 0.000 claims description 12
- 210000003041 ligament Anatomy 0.000 claims description 10
- 230000000926 neurological effect Effects 0.000 claims description 9
- 230000003115 biocidal effect Effects 0.000 claims description 7
- 230000001684 chronic effect Effects 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 210000004400 mucous membrane Anatomy 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 208000011580 syndromic disease Diseases 0.000 claims description 7
- 230000001154 acute effect Effects 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 230000002757 inflammatory effect Effects 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 6
- 210000002784 stomach Anatomy 0.000 claims description 6
- 208000007882 Gastritis Diseases 0.000 claims description 5
- 208000007542 Paresis Diseases 0.000 claims description 5
- 208000006735 Periostitis Diseases 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 230000004054 inflammatory process Effects 0.000 claims description 5
- 230000000626 neurodegenerative effect Effects 0.000 claims description 5
- 201000008482 osteoarthritis Diseases 0.000 claims description 5
- 206010061218 Inflammation Diseases 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 208000000509 infertility Diseases 0.000 claims description 4
- 230000036512 infertility Effects 0.000 claims description 4
- 231100000535 infertility Toxicity 0.000 claims description 4
- 244000045947 parasite Species 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- 241000282326 Felis catus Species 0.000 claims description 3
- 229920001917 Ficoll Polymers 0.000 claims description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 3
- 229930182566 Gentamicin Natural products 0.000 claims description 3
- 241000282412 Homo Species 0.000 claims description 3
- 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 claims description 3
- 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 229960002518 gentamicin Drugs 0.000 claims description 3
- 238000010253 intravenous injection Methods 0.000 claims description 2
- 206010017076 Fracture Diseases 0.000 claims 2
- 230000000052 comparative effect Effects 0.000 claims 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 14
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 238000001990 intravenous administration Methods 0.000 description 10
- 238000001727 in vivo Methods 0.000 description 8
- 210000001778 pluripotent stem cell Anatomy 0.000 description 8
- 238000002604 ultrasonography Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000030175 lameness Diseases 0.000 description 5
- 210000001616 monocyte Anatomy 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 208000002881 Colic Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 2
- 206010061728 Bone lesion Diseases 0.000 description 2
- 241001112696 Clostridia Species 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 2
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 2
- 206010043276 Teratoma Diseases 0.000 description 2
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 210000004439 collateral ligament Anatomy 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 238000002575 gastroscopy Methods 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000009191 jumping Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003789 metatarsus Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 210000002261 nucleate cell Anatomy 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- KLLLJCACIRKBDT-UHFFFAOYSA-N 2-phenyl-1H-indole Chemical compound N1C2=CC=CC=C2C=C1C1=CC=CC=C1 KLLLJCACIRKBDT-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 150000001887 cortisones Chemical class 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 210000004124 hock Anatomy 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000018883 loss of balance Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000002979 macrophagic effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000450 navicular bone Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008196 pharmacological composition Substances 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2006A000498 | 2006-09-20 | ||
| IT000498A ITRM20060498A1 (it) | 2006-09-20 | 2006-09-20 | Metodo di espansione di cellule staminali adulte da sangue periferico e relativi usi in campo medico |
| PCT/EP2007/059531 WO2008034740A1 (en) | 2006-09-20 | 2007-09-11 | Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2007299043A1 AU2007299043A1 (en) | 2008-03-27 |
| AU2007299043B2 true AU2007299043B2 (en) | 2013-06-27 |
Family
ID=38126399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007299043A Ceased AU2007299043B2 (en) | 2006-09-20 | 2007-09-11 | Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8263400B2 (enExample) |
| EP (1) | EP2076588B1 (enExample) |
| JP (1) | JP5340941B2 (enExample) |
| KR (1) | KR101570446B1 (enExample) |
| CN (1) | CN101553565B (enExample) |
| AU (1) | AU2007299043B2 (enExample) |
| BR (1) | BRPI0715036A2 (enExample) |
| CA (1) | CA2663072C (enExample) |
| DK (1) | DK2076588T3 (enExample) |
| EA (1) | EA019305B1 (enExample) |
| ES (1) | ES2435080T3 (enExample) |
| HR (1) | HRP20131104T1 (enExample) |
| IL (1) | IL197575A (enExample) |
| IT (1) | ITRM20060498A1 (enExample) |
| MX (1) | MX2009003059A (enExample) |
| PL (1) | PL2076588T3 (enExample) |
| RS (1) | RS53039B (enExample) |
| SI (1) | SI2076588T1 (enExample) |
| WO (1) | WO2008034740A1 (enExample) |
| ZA (1) | ZA200901748B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9132116B2 (en) | 2004-08-02 | 2015-09-15 | Willowcroft Pharm Inc. | Mast cell stabilizers to prevent or treat laminitis |
| ITUD20080058A1 (it) * | 2008-03-18 | 2009-09-19 | Thankstem S R L | Kit per la raccolta di sangue, preferibilmente periferico, per la produzione di cellule staminali |
| WO2010126544A1 (en) * | 2009-04-29 | 2010-11-04 | Willowcroft Pharm, Llc | Mast cell stabilizers to prevent or treat laminitis |
| KR101202836B1 (ko) * | 2010-08-27 | 2012-11-20 | 서울대학교산학협력단 | 세포응집을 이용한 인간 혈액 유래 혈구 세포괴의 유도와 이를 이용한 혈중 성체줄기세포 및 전구세포의 증폭방법 및 상기의 방법에 의해 제조된 줄기세포 |
| WO2012106367A2 (en) * | 2011-01-31 | 2012-08-09 | Royal Daniel F | Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease |
| BE1020480A5 (nl) | 2012-10-01 | 2013-11-05 | Global Stem Cell Technology | Werkwijze voor de isolatie van mesenchymale stamcellen uit bloed van zoogdieren, en gebruik ervan. |
| CN106574247A (zh) * | 2014-05-09 | 2017-04-19 | 善克思腾(股份)责任有限公司 | 从全血中扩增成体干细胞的方法 |
| RU2644650C2 (ru) | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
| WO2016204230A1 (ja) * | 2015-06-17 | 2016-12-22 | 仁幸 小林 | 幹細胞投与方法、競走馬または競技馬の症状改善方法、注射用容器および幹細胞注射セット |
| RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
| CA3028422A1 (en) * | 2016-06-23 | 2017-12-28 | Tithon Biotech, Inc. | Cells expressing parathyroid hormone 1 receptor and uses thereof |
| US11103537B2 (en) | 2016-06-23 | 2021-08-31 | Tithon Biotech Inc. | Cells expressing parathyroid hormone 1 receptor and uses thereof |
| BR112021023101A2 (pt) * | 2019-05-22 | 2022-01-04 | Thankstem S R L | Método para expansão de células-tronco adultas do sangue total |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003083092A1 (en) * | 2002-03-28 | 2003-10-09 | Blasticon Biotechnologische Forschung Gmbh | Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| WO2004043990A2 (en) * | 2002-11-07 | 2004-05-27 | University Of Chicago | Human stem cell materials and methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1436843A (zh) * | 2002-02-08 | 2003-08-20 | 刘颉 | 脐血造血干细胞的制作方法 |
| CN1667119A (zh) * | 2004-03-11 | 2005-09-14 | 中国人民解放军第二军医大学 | 一种成体干细胞及其培养方法和用途 |
-
2006
- 2006-09-20 IT IT000498A patent/ITRM20060498A1/it unknown
-
2007
- 2007-09-11 KR KR1020097007818A patent/KR101570446B1/ko active Active
- 2007-09-11 PL PL07820134T patent/PL2076588T3/pl unknown
- 2007-09-11 JP JP2009528679A patent/JP5340941B2/ja not_active Expired - Fee Related
- 2007-09-11 DK DK07820134.0T patent/DK2076588T3/da active
- 2007-09-11 ES ES07820134T patent/ES2435080T3/es active Active
- 2007-09-11 EA EA200970294A patent/EA019305B1/ru not_active IP Right Cessation
- 2007-09-11 SI SI200731352T patent/SI2076588T1/sl unknown
- 2007-09-11 RS RS20130499A patent/RS53039B/sr unknown
- 2007-09-11 AU AU2007299043A patent/AU2007299043B2/en not_active Ceased
- 2007-09-11 CN CN200780034935.XA patent/CN101553565B/zh active Active
- 2007-09-11 EP EP07820134.0A patent/EP2076588B1/en active Active
- 2007-09-11 WO PCT/EP2007/059531 patent/WO2008034740A1/en not_active Ceased
- 2007-09-11 BR BRPI0715036-9A patent/BRPI0715036A2/pt not_active Application Discontinuation
- 2007-09-11 HR HRP20131104TT patent/HRP20131104T1/hr unknown
- 2007-09-11 MX MX2009003059A patent/MX2009003059A/es active IP Right Grant
- 2007-09-11 CA CA2663072A patent/CA2663072C/en active Active
-
2009
- 2009-03-11 ZA ZA200901748A patent/ZA200901748B/xx unknown
- 2009-03-12 IL IL197575A patent/IL197575A/en active IP Right Grant
- 2009-03-20 US US12/408,145 patent/US8263400B2/en active Active
-
2012
- 2012-08-16 US US13/587,417 patent/US20120308535A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003083092A1 (en) * | 2002-03-28 | 2003-10-09 | Blasticon Biotechnologische Forschung Gmbh | Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| WO2004043990A2 (en) * | 2002-11-07 | 2004-05-27 | University Of Chicago | Human stem cell materials and methods |
Non-Patent Citations (1)
| Title |
|---|
| Zhao Y et al, Proceedings of the National Academy of Sciences, 2003, 100(5):2426-2431 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2076588A1 (en) | 2009-07-08 |
| US20120308535A1 (en) | 2012-12-06 |
| EA200970294A1 (ru) | 2009-10-30 |
| IL197575A0 (en) | 2011-08-01 |
| BRPI0715036A2 (pt) | 2013-05-28 |
| US20100068189A1 (en) | 2010-03-18 |
| RS53039B (sr) | 2014-04-30 |
| US8263400B2 (en) | 2012-09-11 |
| ITRM20060498A1 (it) | 2008-03-21 |
| JP2010504083A (ja) | 2010-02-12 |
| JP5340941B2 (ja) | 2013-11-13 |
| AU2007299043A1 (en) | 2008-03-27 |
| CN101553565B (zh) | 2015-05-06 |
| SI2076588T1 (sl) | 2013-12-31 |
| PL2076588T3 (pl) | 2014-01-31 |
| CA2663072C (en) | 2016-01-19 |
| HK1138315A1 (en) | 2010-08-20 |
| DK2076588T3 (da) | 2013-11-11 |
| KR20090074044A (ko) | 2009-07-03 |
| MX2009003059A (es) | 2009-04-01 |
| WO2008034740A1 (en) | 2008-03-27 |
| CN101553565A (zh) | 2009-10-07 |
| KR101570446B1 (ko) | 2015-11-27 |
| CA2663072A1 (en) | 2008-03-27 |
| IL197575A (en) | 2013-06-27 |
| HRP20131104T1 (hr) | 2013-12-20 |
| ZA200901748B (en) | 2010-03-31 |
| ES2435080T3 (es) | 2013-12-18 |
| EA019305B1 (ru) | 2014-02-28 |
| EP2076588B1 (en) | 2013-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007299043B2 (en) | Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field | |
| JP2010504083A5 (enExample) | ||
| US9387226B2 (en) | Neural cell proliferation induced through the culture of neural cells with umbilical cord blood-derived mesenchymal stem cells | |
| US20060247195A1 (en) | Method of altering cell properties by administering rna | |
| JP2001515505A (ja) | 軸索再生を促進する単核貪食細胞及びその使用 | |
| US8500712B2 (en) | Kit for collecting blood, preferably peripheral blood, for the production of stem cells | |
| KR100959995B1 (ko) | 인간 제대혈 유래 간엽 줄기세포를 유효성분으로 포함하는,신경전구세포 또는 신경줄기세포의 신경세포로의 분화 및증식 유도용 조성물 | |
| CN106011173A (zh) | 一种抑制神经二次损伤的人少突胶质祖细胞的制备方法及其试剂盒与应用 | |
| JP6994200B2 (ja) | 多能性幹細胞による周産期脳障害の改善及び治療 | |
| CN113583948B (zh) | Cd200+亚群脐带间充质干细胞的培养方法及其所用的培养基 | |
| EA035104B1 (ru) | Способ размножения взрослых стволовых клеток из цельной крови | |
| Peng et al. | Hyperbaric oxygen therapy combined with Schwann cell transplantation promotes spinal cord injury recovery | |
| US10765706B2 (en) | Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers | |
| HK1138315B (en) | Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field | |
| RU2413523C2 (ru) | Способ лечения посттравматической энцефалопатии | |
| RU2286160C1 (ru) | Способ лечения травматических повреждений спинного мозга | |
| CN116669747A (zh) | 具有正常核型的新型nr1 es源性神经干细胞及其用途 | |
| WO2019237106A1 (en) | Compositions and methods for treating stroke |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: THANKSTEM SRL Free format text: FORMER APPLICANT(S): SALES ENGINEERING AG |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |